Hereditary Cancer Risk Screening
Create a requestHereditary Cancer Risk Screening is a preventive medical process aimed at identifying the potential risk of developing certain types of cancers based on one’s genetic makeup. By analyzing specific genes that are known to increase cancer risk, this screening can provide individuals and families with crucial information about their health futures.
General
Hereditary Cancer Risk Screening involves the analysis of DNA, usually through a blood or saliva sample, to identify mutations in genes that are associated with an increased risk of developing certain types of cancer. These genes, such as BRCA1 and BRCA2 for breast and ovarian cancer, can substantially elevate an individual’s risk compared to the general population. Understanding these risks can guide decisions about preventive measures, lifestyle adjustments, and the timing and frequency of cancer screening tests. The process is a powerful tool for cancer prevention and early detection, which is especially critical for highly treatable cancers when caught early. It's crucial for individuals with a family history of cancer to consider this screening, as inherited genetic mutations play a significant role in 5% to 10% of all cancers.
Special Details
Who is it for?
Individuals with a family history of cancer, particularly if the cancer appeared at an early age or affected several family members.
People who have already had cancer, to assess their risk of developing a second type of cancer.
Individuals from ethnic groups with a higher prevalence of specific gene mutations, such as Ashkenazi Jewish descent with increased BRCA1 and BRCA2 mutations.
Recovery Period
The procedure itself is non-invasive and requires no recovery time.
Results typically take 2-4 weeks to process.
Follow-up care may vary based on results and can range from routine monitoring to proactive preventive measures.
Potential Risks and Side Effects
False positive or negative results, leading to unnecessary anxiety or a false sense of security.
Psychological stress from learning one's genetic risk.
Potential discrimination in insurance and employment based on genetic information, despite legal protections in some countries.
Alternative Treatments
Regular screening and monitoring based on general population guidelines, without genetic testing.
Lifestyle changes and medications aimed at reducing cancer risk in individuals without specific genetic risk identification.
Success Rate
Success in terms of accuracy is high, with modern genetic sequencing technologies offering over 99% specificity and sensitivity for detected mutations.
Procedure step-by-step overivew
Consultation with a healthcare provider to assess need and discuss implications.
Collection of the sample, typically through a blood draw or saliva collection.
Sample is sent to a laboratory specializing in genetic testing.
DNA is extracted from the sample and analyzed for specific genetic mutations.
Results are reviewed by a healthcare professional and communicated to the individual.
Follow-up consultation to discuss results, implications, and next steps.
Prices
Turkey
$250 - $600
Czech Republic
$300 - $700
Croatia
$350 - $750
Lithuania
$300 - $650
Poland
$250 - $700
Germany
$400 - $900
Switzerland
$600 - $1200
France
$350 - $800
United Kingdom
$400 - $900
United States
$300 - $3000
Canada
$250 - $700
Australia
$300 - $800
Why Do Prices Vary?
Type of genetic tests conducted (some panels screen for more genes than others).
Geographic location and the lab's pricing policy.
Insurance coverage and out-of-pocket costs.
Additional consultations with genetic counselors or specialists.
Related Blog Posts
Unlock Your Genetic Potential Without Spending a Fortune: Why Smart Patients Fly to Turkey for Executive Check-ups
